Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Antonio Vitiello and Raffaele Porta.
Antonio Vitiello
Connection Strength
1.609
Raffaele Porta
  1. Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks? Ir J Med Sci. 2021 Nov; 190(4):1637-1638.
    View in: PubMed
    Score: 0.924
  2. COVID-19 pandemic: vaccine and new monoclonal antibodies, point of view. Ir J Med Sci. 2022 Feb; 191(1):487-488.
    View in: PubMed
    Score: 0.233
  3. Remdesivir and COVID-19. Ir J Med Sci. 2021 08; 190(3):1237-1238.
    View in: PubMed
    Score: 0.227
  4. Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times? Indian J Pharmacol. 2020 Sep-Oct; 52(5):441-442.
    View in: PubMed
    Score: 0.225
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.